LEGEND BIOTECH
Live / Registered — Registered (as of 12 Aug 2025)
What this means for you
Registered since 12 Aug 2025. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98880290
- Registration number
- 7890671
- Mark type
- Stylized text
- Filed
- 02 Dec 2024
- Published for opposition
- 24 Jun 2025
- Registered
- 12 Aug 2025
- Attorney of record
- Preetha Chakrabarti
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals and medical preparations for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; sanitary preparations for medical purposes; dietetic food and substances adapted for medical use; biological preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; biological tissue cultures for medical purposes; chemical preparations for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; chemical preparations for pharmaceutical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; drugs for medical purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; immunostimulants; medicines for human purposes, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceutical preparations, namely, autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; Pharmaceutical compositions for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; stem cells for medical purposes; Injectable pharmaceuticals for autoimmune diseases, non-communicable diseases, cancer or tumor, or infectious diseases; anti-cancer drugs; Anti-cancer preparations; Compounds for treating cancer; Pharmaceutical preparations and substances for the treatment of cancer; Anti-cancer preparations from hormones and antagonists; Biopharmaceuticals for the treatment of cancer; Biological preparations for the treatment of cancer; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical products for the treatment of cancer; Pharmaceutical preparations and substances for the prevention of cancer; Cell growth media for growing cells for medical use; Cells for medical use, Living cells for medical use; vaccine preparation; Medical diagnostic preparations
- Class 042 — Scientific and technological services: Scientific and technological services, namely, scientific research, analysis, and testing in the field of biotechnology and scientific research and design relating thereto; design and development of computer hardware and software; biological research; chemical analysis; chemical research; chemistry services namely research in the field of chemistry; Scientific research in the nature of conducting clinical trials for others; culturing of cells for scientific research purposes, for others; medical research; research and development of new products for others; scientific laboratory services; scientific research; technological research in the field of biotechnology; Cell separation technology research services; Cell separation research services; Cell culture services for scientific and research purposes, for others; Scientific services relating to the isolation and cultivation of human tissues and cells for scientific and research purposes; Scientific research for medical purposes in the area of cancerous diseases; Stem cell research services; Antibody research and development; Pharmaceutical research and development; Medical computer programming
Owner
- LEGEND BIOTECH USA INC., SOMERSET, NJ, US
- LEGEND BIOTECH USA INC., SOMERSET, NJ, US
- LEGEND BIOTECH USA INC., SOMERSET, NJ, US
Prior registrations
Prosecution history
- 12 Aug 2025 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 12 Aug 2025 — REGISTERED-PRINCIPAL REGISTER
- 24 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 24 Jun 2025 — PUBLISHED FOR OPPOSITION
- 18 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 22 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 May 2025 — ASSIGNED TO EXAMINER
- 02 Dec 2024 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 02 Dec 2024 — NEW APPLICATION ENTERED